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ABSTRACT 
 
INVESTIGATION OF NOVEL PKC TARGETS IN THE REGULATION OF 
AUTOPHAGY 
 
HUMEYRA NUR KALELI 
Molecular Biology, Genetics and Bioengineering, M.Sc. Thesis, December 2019 
Thesis Supervisor: Assoc. Prof. Ozlem Kutlu 
 
Keywords: Autophagy, protein kinase C, Lentivirus transduction 
Protein Kinase C (PKC) isozymes are serine/threonine kinases that are important 
for activation and/or inactivation of intracellular signaling pathways and therefore 
regulate cellular metabolism. Autophagy is a degradation mechanism functioning under 
basal conditions and activating under cellular stress including nutrient limitation, 
oxidative stress or abnormal protein accumulation. It is initiated by formation of double 
or multi-membrane vesicles in the cytoplasm. These vesicles engulf the cargo and carry 
it to the lysosome. After the fusion of autophagic vesicle with lysosomes, the cargo is 
degraded, and its constituents are recycled. The signaling pathways regulated by PKC 
isozymes are also involved in autophagy mechanism. However, the interaction between 
autophagy and PKC isozymes is still unclear.  The aim of the study is to find novel 
proteins targeted by PKC isozymes during autophagy mechanism. For this aim, lentiviral 
shRNA library system was used for silencing of the genes in GFP-LC3 stably expressing 
mouse embryonic fibroblast (MEF) transgenic cells (MEF GFP-LC3). Upon activation of 
PKC isozymes, autophagic machinery was examined by GFP-LC3 puncta count, LC3 
shift assay and p62 accumulation. Then the positive clones were selected, and their 
genomic DNA was isolated for target gene sequencing. The genes were identified with 
Sanger sequence analysis and their relationship with PKC isozymes were analyzed by 
using RT-q-PCR. Consequently, the role of target gene in the regulation of autophagy 
was determined by commonly used autophagy techniques. 
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ÖZET 
 
OTOFAJİ DÜZENLENMESİNDE YENİ PKC HEDEFLERİNİN ARAŞTIRILMASI  
HÜMEYRA NUR KALELİ 
Moleküler Biyoloji, Genetik ve Biyomühendislik, Yüksek Lisans Tezi, 2019 
Tez Danışmanı: Doç. Dr. Özlem Kutlu 
 
Anahtar kelimeler: Otofaji, protein kinaz C, Lentivirus gen aktarımı 
Protein Kinaz C (PKC) izozimleri, hücre içi sinyal yollarının aktivasyonunda 
ve/veya inaktivasyonununda önemli olan serin/treonin kinazlardır ve bu nedenle hücresel 
metabolizmayı düzenler. Otofaji bazal koşullar altında çalışan ve besin kıtlığı, oksidatif 
stres veya anormal protein birikimi dahil olmak üzere hücresel stres altında aktive olan 
bir öğütme mekanizmasıdır. Oluşumu sitoplazma içinde çift veya çok membranlı 
veziküller ile başlar. Bu veziküller kargoyu içine alır ve onu lizozoma taşır. Otofajik 
vezikülün lizozom ile birleşmesinden sonra, kargo öğütülür ve bileşenleri geri 
dönüştürülür. PKC izozimleri tarafından düzenlenen sinyal yolları ayrıca otofaji 
mekanizmasında da rol oynar. Buna rağmen, otofaji ve PKC izoenzimleri arasındaki ilişki 
hala belirsizdir. Bu çalışmanın amacı, otofaji mekanizması sırasında PKC izozimlerinin 
hedeflediği yeni proteinleri bulmaktır. Bu amaçla, GFP-LC3 proteinini stabil olarak 
eksprese eden fare embriyonik fibroblast (MEF) transgenik hücrelerinde (MEF GFP-
LC3) lentiviral shRNA kütüphanesi gen susturmak için kullanılmıştır. PKC izozimlerinin 
aktifleşmesi ile, otofajik sistem GFP-LC3 nokta sayısı, LC3 değişim analizi ve p62 
birikimi ile incelenmiştir. Daha sonra pozitif klonlar seçildi ve genomik DNA'ları hedef 
gen dizilimi için izole edildi. Genler Sanger dizi analizi ile tanımlandı ve bunların PKC 
izozimleri ile ilişkileri RT-q-PCR yöntemi kullanılarak analiz edildi. Sonuç olarak, hedef 
genin otofaji düzenlemesindeki rolü, yaygın olarak kullanılan otofaji teknikleri ile 
belirlendi. 
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1. INTRODUCTION  
 
 
 
1.1. Autophagy 
 
The discovery of lysosomes by C. de Duve in the 1950s brings along crucial cellular 
system questions including what the fate across the regulation of lysosome is and how its 
regulation affects the protein- enzyme function (De Duve, Pressman, Gianetto, Wattiaux, 
& Appelmans, 1955). During the investigation of those questions, another research team, 
Marilyn Farquhar and her associates focused on electron microscopy images of cells and 
discovered the existence of several membrane-covered vesicles. Initially, they define 
them as lytic bodies, known as phagophore today. The vesicles engulfed mitochondria, 
ER and ribosomes are called autophagic bodies (Smith & Farquhar, 1966). Investigations 
have been accelerating and autophagosomes, autolysosomes, and even different types of 
autophagy mechanisms were discovered.  
Autophagy is a well-conserved recycling mechanism in the cell to remove cellular waste 
and toxins in order to maintain energy homeostasis. The mechanism promotes survival 
by delaying senescence under stress conditions such as nutrient starvation or oxidative 
stress. In this mechanism, double-membrane vesicles surround non-functional organelles, 
protein aggregates, and cytoplasmic compartments and then these complexes transport 
toward lysosomes for degradation. Cooperation of different autophagy-related proteins 
known as ATG proteins maintain the autophagy stages, which include initiation, 
elongation, maturation, lysosomal fusion and degradation (Figure 2.) (Glick, Barth, & 
Macleod, 2010). Autophagy serves as a house cleaner because both unnecessary proteins 
and cellular organelles are swept to make room for newly built functional materials. 
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Insufficiency of autophagy results in disease progression due to the accumulation of waste 
materials (Levine & Kroemer, 2008).  
mTOR mediated PI3K/Akt activation is well studied signaling pathway and negative 
regulation of mTOR pathway promotes formation of ULK1 complex with ATG proteins 
and initiates phagophore formation (Alers, Löffler, Wesselborg, & Stork, 2012; Jung, Ro, 
Cao, Otto, & Kim, 2010). Lipidation of LC3 results in the conversion of LC3-I to LC3-II 
protein that leads to the expansion of phagophore around recycling materials. Efficient 
fusion of autophagosome with lysosome creates autolysosome, where the waste materials 
are degraded (Nath et al., 2014).  
Autophagy is classified into three main groups: Macroautophagy, microautophagy, and 
chaperone-mediated autophagy (CMA). In macroautophagy, larger molecules, such as 
organelles, protein aggregates that could not be degraded by the proteasomal system are 
recycled. In microautophagy, smaller molecules are directly transported to the lysosome 
and degraded. In chaperone-mediated autophagy, proteins having the KFERQ motif are 
first recognized by Heat Shock Protein 70 (HSP70) and then directed towards lysosome. 
These proteins are further identified by lysosomal membrane protein-2 (LAMP2) and 
engulfed in lysosomes for degradation.  
Figure 1.1. Illustration of autophagy mechanism 
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1.2. Type of Autophagy 
 
 
1.2.1. Macroautophagy 
 
Macroautophagy is the best characterized type of autophagy (Levine & Klionsky, 2017). 
Two main kinase systems known to regulate autophagy namely the mTOR–ULK1 and 
the BECN1 complex. In detail cell’s energy sensor mTOR or TOR is an important kinase 
that regulates cell growth, proliferation, survival, death, and energy metabolism. It 
consists of two sets of proteins, mTORC1 and mTORC2. mTORC1 is involved in cellular 
events such as cell growth, proliferation, and death, while mTORC2 provides the 
regulation of the cellular skeleton. The mTORC1 protein cluster, which plays a role in 
autophagy activation in starvation conditions, consists of proteins called Raptor, mLST8, 
PRAS40, and DEPTOR, which bind to mTOR. When nutrient or growth factors are 
abundant, autophagy protein Ulk1 is phosphorylated by mTOR and this phosphorylation 
results in inactivation of autophagy. The ULK complex contains the ULK1 or ULK2 
kinase, ATG13, FIP200 (focal adhesion kinase-family interacting protein of 200 kDa) 
and ATG101. However, when nutrients and growth factors are limiting in the 
environment or under ER stress, AMP-Kinase (AMP-activated kinase) activated by 
LKB1 (liver kinase B1) via the phosphorylation of the Raptor directly on the mTORC1 
cluster. Alternatively, AMP-Kinase inhibits mTORC1 by blockade of Rheb (Ras-related 
small G protein) pathway via TSC2 inhibition in the upregulated signaling pathway of 
mTORC1. Thus, the formation of autophagosomes is triggered. When activated, 
mTORC1 favors cell growth by promoting translation via the phosphorylation of p70S6K 
(70 kDa polypeptide 1 ribosomal protein S6 kinase) and of 4E-BP1, an inhibitor of 
translation initiation, therein inactivating it (Y. Chen & Klionsky, 2011). 
Another protein complex needed for the formation of autophagosomes is a complex of 
class III phosphatidylinositol 3-kinases (PI3K). The core components of PI3K complex 
are also responsible for the catalytic activity of the complex and these are VPS34 
(vacuolar protein sorting 34), VPS15 and Beclin-1 (BECN1) proteins. PI3P plays a 
crucial role in the clustering of proteins required for autophagic vesicle formation in 
vesicle budding regions and provides a fusion platform for many proteins. 
4 
 
Phosphatidylinositol-3-phosphate (PI3P) constitutes an essential membrane component 
of the elongating isolation membrane and it is generated by VPS34 (Devereaux et al., 
2013). In mammalian cells, PI3P molecules function as recruiting point for several 
autophagy-related proteins to the isolation membrane such as WIPI1/2, DFCP1, and Alfy. 
In addition to that, ATG9 (ATG9L1 in mammals) is also one of the crucial 
transmembrane proteins, plays a role in the lipid delivery and establishes a platform for 
recruiting effectors for the phagophore (Young et al., 2006). 
The autophagic sac elongation involves two separate protein-protein interactions which 
resemble ubiquitination. The first pathway enables the binding of the ubiquitin-like 
ATG12 protein to ATG5 and then the ATG5-ATG12 complex recruits ATG16L to form 
the ATG12-ATG5-ATG16 complex. Here, the ATG7 and ATG10 proteins, which 
regulate the addition of ATG12 in a manner similar to ubiquitination, play the E1 and E2-
like role, respectively (Hanada et al., 2007). The second pathway is the covalent binding 
of phosphatidylethanolamine (PE) to the protein LC3. LC3B protein is synthesized as 
precursor and is a critical component of autophagosome formation. During this formation, 
cysteine protease ATG4 cleaves LC3 from its C-terminus and a glycine residue is 
exposed. Cleaved form of LC3, is activated by ATG7 then transferred to ATG3 through 
covalent binding and linked to an amino group of phosphatidylethanolamines (PE). 
Conjugation of LC3-PE to both sides of the isolation membrane enables them to act as 
surface receptor for the specific recruitment of other proteins (Nakatogawa, Ichimura, & 
Ohsumi, 2007). The autophagosomal closure results in a typical double-membraned 
vacuole formation. 
Apart from AMP-Kinase, PTEN which is one of the tumor suppressors converts PIP3 to 
PIP2 and inhibits mTOR via PI3K / Akt / TSC1-2 pathway so that has a role in autophagy 
regulation. Also, ERK1 / 2 and c-Jun N-terminal kinase1 (JNK1) in Ras / MAPK pathway 
have been found as inducers of autophagy (Obara, Noda, Niimi, & Ohsumi, 2008; Xie & 
Klionsky, 2007). Some of oncogenes such as Class I PI3K, Akt, TOR, Bcl-2 suppresses 
autophagy. Studies have shown that p53, one of the most important tumor suppressor 
genes, plays a dual role in autophagy (Pattingre & Levine, 2006; Tasdemir, Maiuri, 
Morselli, et al., 2008). A number of studies have shown that p53, particularly to the cell 
nucleus, induces autophagy dependent or independent of the effect of transcription 
(Levine & Abrams, 2008; Tasdemir, Maiuri, Galluzzi, et al., 2008). On the other hand, 
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some studies suggest that wild and mutant forms of p53 located in the cytoplasm suppress 
autophagy (Crighton et al., 2006; Feng, Zhang, Levine, & Jin, 2005). In addition, TNF-α 
(Tumor necrosis factor), which plays a fundamental role in many disease mechanisms, 
including cancer, has been shown to activate mTORC1 by phosphorylating the TSC1 
complex (IKKβ) (Lee et al., 2007). 
 
1.2.2. Microautophagy 
Microautophagy involves direct engulfment of the proteins/cytoplasm into the lysosome 
(mammalians) or vacuole (plants and fungi) by invagination. Dynamin-related GTPase 
Vps1p plays an active role to regulate the invagination of microautophagic process. 
Importantly, these invaginations grow and shrink rapidly, and their frequency depends on 
the nutritional conditions. Starvation induces the initiation and extension of invagination 
respectively (Uttenweiler, Schwarz, & Mayer, 2005). During extension, this formation 
specializes into a characteristic tubular shape termed as “autophagic tube”, depending on 
its unique structure and autophagy-related function (Müller et al., 2000). 
The soluble substrates of microautophagy can be induced by N-starvation or rapamycin 
through the regulatory signaling complexes. The maintenance of organelle size, 
membrane homeostasis, and cell survival under N-restriction are considered as main 
functions of microautophagy (W.-w. Li, Li, & Bao, 2012). As a basic form of autophagy, 
microautophagy-dependent lysosomal/vacuolar degradative process is either non-
selective or selective. The non-exclusive microautophagy engulfs soluble intracellular 
substrates by tubular invaginations. Thus, the selective microautophagy sequesters 
specific organelles with arm-like protrusions. The non-selective microautophagy is 
regularly observed in mammalian cells, while the three forms of selective 
microautophagy are frequently induced in yeasts (micropexophagy, piecemeal 
microautophagy of the nucleus (PMN), micromitophagy). 
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1.2.3. Chaperon mediated autophagy 
Chaperone mediated autophagy (CMA) is a selective form of autophagy and it has a 
distinctive way to recognize cargo molecules. In CMA, well known chaperone protein 
heat shock protein 70 (hsp70) recognizes proteins with specific pentapeptide motif 
KFERQ and translocates them to the lysosomal lumen for degradation via lysosomal-
associated membrane protein 2A (LAMP2A) (Kaushik & Cuervo, 2018). CMA activation 
is much crucial for some cellular events such as control of cell cycle (Park, Suh, & 
Cuervo, 2015), CD4+ T cell activation (Valdor et al., 2014), protein quality control 
(Schneider et al., 2015), and response to starvation (Finn & Dice, 2005). In addition, link 
between CMA mechanism and neurodegenerative diseases has been reported. It is known 
that, CMA contributes to the degradation of misfolded proteins, which prone to become 
aggregates. 
 
1.2.4. Selective Autophagy 
For cellular homeostasis, proper clearance of organelles or specific molecules is critical 
in living organisms. In selective autophagy, receptor proteins recognize specific cargo 
such as mitochondria, lipid droplets, invading pathogens etc. These receptor proteins are 
responsible for carrying the cargo to the site of autophagosomal engulfment. So far, 
several specific receptors or adaptor proteins, which regulate the selective degradation of 
specific cargo have been identified and partially characterized. Selective autophagy has 
drawn the attention of researchers because of its potential importance in clinical diseases; 
however, the physiological roles are not yet fully understood.  
 
1.2.4.1. Mitophagy 
Mitochondria are highly dynamic, double-membrane surrounded organelles, which have 
a major function in energy production within the eukaryotic cells. They are involved in a 
variety of cellular functions within eukaryotic cells and have an ancient bacterial origin. 
Besides energy production, they are involved in amino acid synthesis, fatty acid 
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production, heme synthesis, innate immunity (Tait & Green, 2012) as well as 
programmed cell death processes (Green & Kroemer, 2004). 
Considering all these missions of mitochondria, to control its balance according to cell’s 
demand is essential for disease progression. The selective degradation to remove 
damaged mitochondria by autophagy, is called mitophagy (K. Wang & Klionsky, 2011). 
Parkin and PINK1-dependent mitophagy is one of the best-studied forms of mitophagy 
(Matsuda et al., 2010; Narendra, Tanaka, Suen, & Youle, 2008). Mainly, mitophagy is 
maintained by these two famous genes and their loss-of-function mutations are linked to 
early-onset of Parkinson’s Disease.  PTEN-induced putative kinase 1 (PINK1), encodes 
for a mitochondrially localized kinase, and PARK2, encodes a cytosolic E3 ubiquitin 
ligase (Narendra et al., 2008).  Under normal conditions, after being synthesized as a 
precursor in the cytoplasm, PINK1 is imported to mitochondria through translocase of 
the outer membrane (TOM) and translocase of the inner membrane (TIM) complexes. 
When PINK1 is imported, it is post-translationally modified within mitochondria by 
mitochondrial proteases. PINK1 is first cleaved through its N-terminal matrix targeting 
sequence (MTS) by matrix processing peptidases (MPP) and resulting cleavage followed 
by another cleavage by Presenilin-associated rhomboid-like protease (PARL) in the 
matrix (Deas et al., 2011). PARL-mediated N-terminal cleavage results in destabilizing 
Phe104 residue and therefore, when retranslocation from mitochondria to cytoplasm 
emerges, degrades by proteasome through recognition of its N-terminus (Yamano & 
Youle, 2013). Under stress conditions, PINK1 import to mitochondria is blocked, PINK1 
proteins on OMM get dimerized and this dimerization is necessary for 
autophosphorylation events. This accumulated PINK1 phosphorylates various targets, 
including ubiquitin, and recruits the cytoplasmic E3 ubiquitin ligase, Parkin protein. After 
this moment, Parkin acts as an amplifier of the PINK1-generated mitophagy signal 
(Lazarou, Jin, Kane, & Youle, 2012). 
Additionally, AMBRA1 is another key mitophagy regulator that allows proper Parkin-
dependent and independent mitochondrial clearance. It is ubiquitously expressed in adult 
midbrain and found in complex with Parkin but AMBRA1 has no effect on Parkin 
recruitment to mitochondria, its activation effect on PI3K suggested to be critical for 
PINK/Parkin-mediated mitophagy (Strappazzon et al., 2015). 
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1.2.4.2. Lipophagy 
Lipid droplets (LDs) are specialized organelles composed of lipids essential for cellular 
energy (metabolism) and membrane production (Walther & Farese, 2012). LDs consist 
of a neutral lipid namely triglyceride (TG) and cholesterol esters and are coated by a 
phospholipid monolayer and various proteins such as the perilipins (PLINs). Under 
certain conditions like nutrient deprivation, cellular lipids stored as triglycerides in LDs 
are hydrolyzed into fatty acids for energy. As expected second cellular response to 
starvation is the induction of autophagy. Interrelationship between autophagy and lipid 
metabolism was shown in mouse hepatocytes for first time in 2009 by Mochida et al. This 
study revealed that inhibition of macroautophagy, pharmacologically or by silencing of 
the ATG genes, leads to the accumulation of TGs and LDs in serum-starved hepatocytes. 
Thus, nutrient limitation triggers LD degradation by macroautophagy in hepatocytes 
(Mochida et al., 2015). 
Microlipophagy has been detected in yeast in response to nitrogen starvation, glucose 
depletion, survival during stationary phase, and phospholipid imbalance. Under these 
conditions, LDs are taken up into the vacuole at sites of vacuolar membrane invagination 
(Seo et al., 2017; van Zutphen et al., 2014).  
 
 
 
 
 
 
 
 
 
Figure 1.2. Illustration of selective autophagy mechanism  
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1.3. Protein Kinase C Family 
Protein Kinase C (PKC) protein family is a phospholipid-dependent serine/threonine 
kinase that are discovered by Nishizuka and his colleagues in the 1970s.  This protein 
family is initially defined as PKM due to their Mg+2 dependent activations, but later on, 
they are called as PKC due to their Ca+2 dependent activations. Protein kinase family 
consists of over 15 subgroups with more than 500 kinases, each of which is involved in 
the regulation of gene expression therefore, downregulation or upregulation of these 
kinases induces severe consequences in the progression of disorders such as cancer or 
neurodegenerative diseases.  
Due to the regulatory role in cellular activities through interaction of other sig 
nalingproteins, PKCs have a critical role in disease progression. To date, the involvement 
of PKCs in disease progression is being studied in both in vitro and in vivo models as 
well as patient-derived samples. In vivo animal models were designed to analyze the 
development of cancer (Hafeez et al., 2011; Leitges, 2007; Spitaler & Cantrell, 2004), 
neurodegenerative diseases (W. M. Lau et al., 2018; Russo et al., 2018; Sanna, Quattrone, 
Ghelardini, & Galeotti, 2014), metabolic disorders (Jha et al., 2016; Sajan et al., 2018) 
and muscular defects (Madaro et al., 2012; Quack et al., 2011; G.-S. Wang et al., 2009). 
 
1.3.1. Structure and Classification of PKC isozymes  
Protein kinase C (PKC) is the subgroup of the kinase family and comprises ten members. 
The distinguishing feature of PKCs is that they include N-terminal regulatory domain 
connected to C- terminal catalytic domain through a hinge domain (K.-P. Huang, 1989; 
Newton, 1995). Each PKC isozymes has common structural characteristics since they 
have four conserved domains, C1, C2, C3 and C4. C1 and C2 locate on N-terminal 
regulatory domain while C3 and C4 reside on C-terminal catalytic domain. C1 domain is 
composed of 50 amino acid sequence and has C1A and C1B domains. Cysteine and 
histidine residues on C1 domain associate with zinc ions. Zn+2 association is important 
because of protection of the conservation of tertiary structure. C1 domain structure shows 
that it has hydrophilic ligand binding site enclosed with hydrophobic amino acids. On 
hydrophilic region, there are diacylglycerol (DAG) and phorbol esters binding sites 
(Schultz, Ling, & Larsson, 2004). When DAG and phorbol esters bind on that region, C1 
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domain becomes completely hydrophobic and this configuration enables C1 domain to 
translocate and bind to the membrane (Schultz et al., 2004). C1 domains are activated by 
different lipids and the situation causes difference in activation of some PKCs within 
same subgroup. C2 is consist of 130 amino acids which include secondary messenger, 
Ca+2, binding site (Johnson, Giorgione, & Newton, 2000). Among protein kinases, 
sequences of C2 domain do not show homology and have diverse differences. Because 
of the differences, C2 domain has distinctive functions as protein phosphorylation or lipid 
modification. There are three Ca+2 binding sites on C2 domain facilitating interaction with 
phosphatidylserine at the membrane and resulting in conformational change of PKCs 
(Bolsover, Gomez-Fernandez, & Corbalan-Garcia, 2003; Edwards & Newton, 1997). C3 
has ATP binding site and C4 has protein substrate binding sites (Ramos, Reyes-Reyes, & 
Nanez, 2018). All PKC isozyme has pseudo-substrate region that is a substrate-
mimicking short amino acid sequence that binds the substrate-binding site in the catalytic 
domain, inhibiting the enzyme activity (Yang, Langston, Tang, Kiani, & Kilpatrick, 
2019) In the latent form, the N-terminal pseudo-substrate (PS) region which is acting as 
autoinhibitory region on PKC renders the active site, which is located between the two 
lobes of the catalytic domain (Igumenova, 2015). 
Based on structural features and activators, PKCs classify split into three categories. 
Conventional PKCs consist of PKCα, PKCβI, PKCβII, and PKCγ. Novel PKCs consist 
of PKCδ, PKC η, PKC θ, and PKC ε. Atypical PKCs consist of PKC ζ and PKC ι/λ 
(Steinberg, 2008). 
 
Figure 1.3 Domain structures of PKC isozymes.  
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1.3.2. Activation and Function of PKC isozymes 
PKCs stay at the resting state without secondary messengers. Hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) leads to diacylglycerol (DAG) and inositol 
1,4,5- trisphosphate (IP3) formation. IP3 translocates to ER and initiates intracellular Ca+2 
release (Spitaler & Cantrell, 2004). This secondary messenger mobile to C2 domain of 
PKC and bind on “region”. Binding of Ca+2 changes affinity of C2 domain for membrane. 
Conformational change and translocation to the membrane happen. When PKCs reach to 
membrane, they interact with PS to enable strong membrane penetration. Interaction with 
Ca+2 is not enough to activate conventional PKCs because they also need DAG and 
phorbol for activation. When DAG and phorbol esters bind to C1 domain, PKCs become 
active and stimulate downstream signaling pathways. Foremost, phosphatidylserine 
interacts with C1 domain and provide suitable circumstance for binding of DAG 
(Steinberg, 2008). When Ca+2, DAG and phosphatidylserine collaborate, conformational 
change PKCs at membrane occurs in order to remove pseudo-substrate sequence. In 
comparison to conventional PKCs, novel PKCs do not require Ca+2 for activation by 
reason of their C2 domain sequence variation on Ca+2 binding site. So that their activation 
via Ca+2 does not proceed. Accordingly, novel PKCs only require DAG and PS for the 
initiation of signaling cascades. At last, atypical PKCs consist of PKC ζ and PKC ι/λ, 
which only need DAG for activation.   
 
Figure 1.4 Activation of Protein Kinase C 
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1.3.3. PKC in Autophagy Mechanism 
Activation of Protein kinase C isozymes is involved in extensive cellular mechanisms, 
including the autophagy pathway. Each isozyme has a diverse role in the pathway due to 
its phosphorylation abilities. Various functions of PKCs in main autophagy pathways 
such as PI3K / Akt / mTOR have been reported in several studies. 
 
It has been described that, PKCα suppresses autophagy by inducing expression of miR-
129-2 in maternal diabetes and provokes neural tube defects (F. Wang et al., 2017). In 
another study, tetrandrine, which is a PKCα inhibitor, causes autophagy induction in 
breast cancer cells through the AMPK independent and mTOR dependent mechanism 
(Wong et al., 2017). On the other hand, Xue et al. showed that the inhibition of PKCα 
causes lysosomal dysfunction and abnormalities in autophagosome-lysosome fusion in 
NRK-49F cells. Thus, the recovery of autophagic flux by PKCα activation resulted in 
kidney fibrosis through TGFβ-1 induction (Xue et al., 2018).  Cisplatin, a 
chemotherapeutic agent, has a role for initiating several signaling pathways in order to 
activate cell death. The expression of PKCβ is promoted by cisplatin treatment in HeLa 
cells.  When PKCβ is silenced, suppression of cisplatin-induced apoptosis was observed 
while formation of cisplatin-induced autophagy was promoted (N. Li & Zhang, 2017). 
Another drug, clozapine used in schizophrenia therapy, has a role in autophagy 
regulation. PKCβ restriction by ruboxistaurin increase clozapine-induced lipophagy and 
causes the recycling of lipid accumulation both in vitro and in vivo (Rimessi et al., 2017). 
Conventional PKCγ reduces neuron-specific autophagy via phosphorylation of mTOR on 
serine 2448 and serine 2481 (Hua et al., 2018). It has been reported that cPKCγ provokes 
the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1) and is involved in the ERK-
mTOR mediated autophagy during ischemic neural injury (Dan Zhang et al., 2017). 
Moreover, inhibition of PKCδ has a role in the correction of nephrotoxicity in kidneys by 
upregulating autophagy through blockage of cisplatin-induced mTOR, AKT, and ULK1 
pathway (Dongshan Zhang et al., 2017b). Similarly, PKCδ was used to phosphorylate 
GSK3αβ and suppress autophagy under Cadmium-induced Heme oxygenase-1 (HO-1) 
expression (So & Oh, 2016). Inhibition of PI3K/Akt/mTOR pathway through PKCδ 
results in impairment of autophagic flux in neural retina cells (S.-P. Huang, Chien, & 
Tsai, 2015). PKCε has a role in lipid metabolism by participating in hepatocyte autophagy 
(Yan, Niu, & Tian, 2018). Reversely, PKCε suppresses autophagy in glioblastoma cells 
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(Toton et al., 2018). Another isozyme, PKCθ, activation in Epstein-Barr virus (EBV)- 
infected cells causes phosphorylation of p38 and MAPK where it leads to autophagy 
induction (Gonnella et al., 2015). Hypoxic-induced autophagy is enhanced under 
calcium-dependent PKCθ activation (Jin et al., 2016). Interestingly, under pathogenic 
infection, autophagy mechanism is upregulated due to an increase in the pathogen’s 
phagosomal escape, and PKCη silencing results in suppression of ATG7, an essential 
protein in autophagosome formation.  Even though ATG7 levels decreased in the absence 
of PKCη, the number of phagosomes is not changed. Therefore, PKCη in autophagy 
regulation may have indirect effects and is subjected for further research (Micheva-
Viteva, Shou, Ganguly, Wu, & Hong-Geller, 2017). 
PKCι downregulates autophagic flux by repressing LC3 conversion. Accordingly, PKCι 
knockdown resulted in autophagic degradation of Hsc70 through CMA independent 
degradation (B.-S. Wang et al., 2013). Also, downregulation of PKCι promotes 
autophagic degradation of β-catenin, independent of CMA (B.-S. Wang et al., 2014). In 
another study, PKCι knockdown induces autophagy via the restriction 
of PI3K/Akt/mTOR pathway. Overexpression of mutant PKCι protein induces 
autophagosome formation and depletion in p62 protein. So, they suggested that 
overexpression of mutant PKCs may be used as antagonists of wild type PKCι for the 
upregulation of autophagy (Qu et al., 2016). 
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2. AIM OF THE STUDY 
 
 
 
In the literature, studies showed that some PKC isozymes have role in the regulation of 
autophagy; yet, the exact mechanism of the relationship between autophagy and PKC 
isozymes is still unclear. In this project, we aimed to find novel proteins targeted by PKC 
isozymes during autophagy mechanism by shRNA-based target gene screening. 
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3. MATERIALS  
 
3.1. Cell Culture 
Table 3.1 Cell Culture Solutions & Reagents 
Cell Culture Reagents Supplier 
Dulbecco's Modifed Eagle's 
Medium 
PAN Pan-P04-03500 
Fetal Bovine Serum (FBS) PAN P30-3304 
Penicillin/Streptomycin (100X) PAN-P06-07100 
L-Glutamine PAN P04-80100 
1x MEM Non-Essential Aminoacid Gibco 11140-35 
EBSS Biological Industries BI02-010-1A 
Lipofectamine 2000 Invitrogen 11668-19 
Trypsin-EDTA 
(0.5 mM EDTA, 0.025% Trypsin) 
PAN P10-019100 
Phosphate Buffer Saline PAN PAN-P04-036503 
FuGENE 6 Promega E2691 
PEI Polysciences, Inc. 23966 
Opti-MEM Gibco 31985-047 
G-418 Roche 04727894001 
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3.2. Plasmids for Transfection 
Table 3.2 List of Plasmid 
Plasmids Supplier 
PKCδ Addgene 
shPKCδ Addgene 
siTRPV6 Dharmacon SO-2747429G 
pCDNA3.1 Addgene 
pMAX-GFP Lonza vpd-1001 
psPAX2 Addgene12260 
pMD2.G Addgene12259 
pRSI9-U6-(sh)-UbiC-TagRFP-2A-Puro Addgene 28289 
DECIPHER Lentiviral shRNA Library 
MM1 
Addgene 28287 
 
3.3. Antibodies for Immunouorescence and Western Blotting 
Table 3.3 List of Antibodies 
Antibody Company 
Actin Sigma A5441 
SQSTM1 BD Transduct Lab 610832 
LC3 Sigma 7543 
TRPV6 Alomone Lab A036 
PKC δ Santa Cruz sc213 
Secondary anti-mouse ImmunoResearch Lab 115035003 
Secondary anti-rabbit ImmunoResearch Lab 111035144 
 
3.4. General Kits  
Table 3.4 List of Kits 
Kit Company 
QIAquick PCR purification kit QIAGEN 28704 
ECL Roche 1201520001 
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NucleoBondTM Xtra Midi Plus Macherey-Nagel 740420 
SYBR Green Roche 04887352001 
Genomic DNA Isolation Kit QIAGEN 69504 
Amaxa Nucleofector™ Kits for Human 
Dermal Fibroblast (NHDF) 
Lonza vpd-1001 
 
3.5. Chemicals and Reagents 
Table 3.5 Chemicals & Reagents 
12 Brand 
2-Mercaptoethanol Neofroxx 1414 
2-Propanol Neofroxx 1496 
LB Broth Agar Caisson Labs LBP03 
Agarose Sigma A9539 
Albumin Fraction V (Bovine Serum 
Albumin, BSA) 
Sigma A3059 
Ammonium persulfate (APS) Neofroxx 1610 
Ampicillin Neofroxx 1728GR010 
Bradford Reagent Sigma B6916 
Bromophenol blue PanReac Applichem A3640 
Calcium chloride-dihydrate Merck A1229282 
Ceramide Santa Cruz Sc3527 
Chloroform Sigma C2432 
DMSO Sigma D2650 
dNTP-Mix, 20mM GeneOn 
Ethanol InterLAB 
Ethylene diamine tetra acetate (EDTA) Neofroxx 1108 
50bp DNA Ladder New England BioLabs N3236S 
Glycerol Neofroxx 1280LT001 
Glycine Neofroxx 1154 
HCl Sigma 7102 
HEPES Sigma H6147 
Methanol InterLAB 
Kanamycin Neofroxx 1162gr010 
Milk powder Neofroxx 1172 
Nonidet P40 Applichem A1694 
Nitrocellulose Membrane Milipore IPVH00010 
Nuclease free water Roche 03315843001 
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PageRuler Prestained Protein Ladder ThermoFisher 26616 
Paraformaldehyde Sigma 158127 
PMA Milipore 524400 
PMSF Sigma P7626 
Potassium chloride Neofroxx 1197 
Protease Inhibitors Sigma P8340 
RNase Inhibitor ThermoFisher EO0382 
SDS Neofroxx 3250 
Sodium Azide Riedel de Haen 13412 
Sodium chloride Neofroxx 1236 
Tetramethylethylenediamine (TEMED) Sigma T7024 
Tris (tris-hydroxymethyl-aminomethane) Sigma T1503 
GENEzol RNA Isolation Reagent Geneaid GZR100 
Tween 20 Neofroxx 8506 
Dream Taq DNA polymerase ThermoFisher EP0701 
DNase I ThermoFisher EN0521 
Revertaid reverse transcriptase ThermoFisher EP0441 
Random hexamer ThermoFisher SO142 
Ribolock RNase ThermoFisher EO0381 
PVDF WB Membrane Roche 03010040001 
RNase Exitus Plus Applichem A7153 
 
3.6. Buffers and Solutions 
Table 3.6 Preparation of Buffer and Solutions 
Buffer/Solution Component 
RIPA Buffer 25mM Tris 
125 mM NaCl 
1% NP40 
0.5% Sodium deoxycolate 
0.1% SDS 
0.004% sodium azide 
pH 8.0 
4XProtein Loading Dye 200mM TrisHCl pH 6.8 
8% SDS 
50% Glycerol 
4% mercaptoethanol 
50 mM EDTA 
0.08% Bromophenol Blue 
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15% Seperating Gel 375 mM TrisHCl pH 8.8 
0.1% SDS 
15% Acrylamide:Bisacrylamide 
0.05%  APS 
0.005% TEMED 
10% Seperating Gel 375 mM TrisHCl pH 8.8 
0.1% SDS 
10% Acrylamide:Bisacrylamide 
0.05% APS 
0.005% TEMED 
4% Stacking Gel 0.125 mM TrisHCl pH 6.8 
0.1% SDS 
4% Acrylamide:Bisacrylamide 
0.05% APS 
0.0075% TEMED 
PBST 3.2 mM Na2HPO4 
0,5 mM KH2PO4 
1,3 mM KCl 
135 mM NaCl 
0,05% Tween 20 
pH 7.4 
2xHBS 140 mM NaCl 
1,5 mM Na2HPO4 
50 mM HEPES 
4% Paraformaldehyde (PFA) 150 mM NaCl 
1% NP40 
0.5% Sodiumdeoxycolate 
0.1% SDS 
50 mM Tris pH 7.4 
Red Solution 5% BSA, 
0.02% Sodium Azide in PBST 
Phenol red 
pH 7.5 
3X protein loading dye 6% SDS 
30% Glycerol 
16% β-Mercaptoethanol 
0.1% Bromophenol blue 
in 1 M Tris-HCl pH 6.8 
ECL solution 25 mM luminol 
9 mM coumeric acid, 
70 mM Tris-HCl pH 8.8 
50X TAE 2M Tris 
0.5M EDTA 
1M Glycial Acetic Acid 
ddH2O up to 1 lt 
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3.7. Software and Websites 
Table 3.7 List of Software and Websites 
Name Purpose 
ImageJ Image analysis 
http://www.ensembl.org/index.html Genome sequence analysis 
https://www.uniprot.org/ Genome sequence analysis 
https://primer3plus.com/ Primer design program 
https://www.addgene.org/ Vector map analysis 
GPS 2.0 Phosphorylation Site Identification 
Phosphomotif Phosphorylation Site Identification 
DISPHOS Phosphorylation Site Identification 
KinasePhos2.0 Phosphorylation Site Identification 
NetPhos 3.1 Phosphorylation Site Identification 
NetPhorest Phosphorylation Site Identification 
PKIS Phosphorylation Site Identification 
PhosphoPick Phosphorylation Site Identification 
Muside Phosphorylation Site Identification 
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4. METHODS 
 
4.1. Cell Culture 
 
Mouse embryonic fibroblast (MEF) GFP-LC3 transgenic cells and HeLa cells stably 
expressing LC3 were maintained in Dulbeco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml 
penicillin/streptomycin, 2 mM L-glutamine and 1x MEM non-essential amino acid 
solution. For MEF GFP-LC3 single cell monoclones, puromycin (3µg/ml) was added into 
complete medium. For HeLa GFP-LC3 stable cells, G-418 (0,6mg7ml) was added into 
complete medium.  Cells were maintained at 370C with 5% CO2. Starvation induced 
autophagy was established by treatment of cells with Earl’s balanced salt solution (EBSS) 
for 2 hours. PMA (100nM) and ceramide (1µM) treatments were performed for 30 
minutes.  
For cryopreservation of cells, cells in 10cm culture dishes were detached with trypsin and 
counted. Each cryopreservation tubes contained at least 1,5 million of cells. Cryotubes 
were prepared with 900 µl cell suspension and 100 µl DMSO. Cryotubes including cells 
were froze in cryobox including isopropanol and stored at -80oC overnight. Next day, 
cryotubes were transferred to liquid nitrogen tank for long term preservation.   
For cell thawing, cells preserved into nitrogen tank were taken and thawed into 37oC 
water bath for 15 seconds. Then they were transferred into 15 ml falcon tube including 5 
ml complete medium. Cell suspension was centrifuged at 300g for 5 minutes and pellet 
was dissolved into 8 ml complete medium and seed in 10 cm culture plate.  
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4.2. Decipher Lentiviral shRNA library Transduction 
 
DECIPHER lentiviral shRNA library, Mouse Module 1: Pathway Targets comprises 
27,000 shRNAs targeting 5,000 gene sequences and carries a puromycin-resistance 
cassette. Calcium- phosphate transfection method was used for transduction of lentiviral 
shRNA library. HEK293T cells were transduced with 10 µg lentivirus vector, 8 µg 
psPAX2 and 2 µg pmD2.G in DMEM containing 10%FBS, 2mM L-Glutamine and 
100U/ml penicillin/streptomycin. Total volume of plasmid mixture was completed to 225 
µl with Hyclone water and 25 µl 2.5 M CaCl2 was added. This mixture was added onto 
250 µl of 2xHBS dropwise. 8 hours later, cells were washed with 1X PBS three times, 
and fresh media was added. After 24 hours, media containing lentiviruses were collected 
and fresh media were added. 36 hours later, media were harvested again and combined 
with the previously collected media and centrifuged at 300 × g for 5 minutes. Supernatant 
was filtered with 0,45 µm filter, aliquoted and stored at -80 °C. MEF GFP-LC3 transgenic 
cells were infected with 100 µl of the lentiviral supernatant. 6 hours later, cells were 
washed, and fresh media were added. After 72 hours, transduction efficiency was checked 
under an Olympus inverted microscope. Transduced cells were selected with 3 μg/mL 
puromycin for 10 days. Single cell colonies were produced.  
4.3. Target Gene Sequencing 
 
4.3.1. Genomic DNA Isolation 
 
Genomic DNA was isolated by QIAamp® DNA Mini Kit as described by the 
manufacturer. Briefly, MEF GFP-LC3 transgenic monoclones were seeded on 10cm cell 
culture dishes (2x 106 cells/dish) and cultured at 370C with 5% CO2. Next day DMEM 
was aspirated and cells were rinsed with 2 ml 1X PBS. For harvest cells, 2 ml 1X PBS 
were put on culture dish and gently scraped with using cell scraper. Cell suspension were 
collected in 15 ml centrifugation tube and centrifuged at 300 × g for 5 minutes at room 
temperature (15–25°C). Supernatant was aspirated and cells were resuspended in 200 µl 
1X PBS. They were transferred into 1,5 ml microcentrifuge tube. 20 μl QIAGEN 
proteinase K was added and vortexed. 200 μl Buffer AL was added to the suspension and 
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mixed by up&down and vortexed for 15 seconds. The susspension were incubated at 560C 
for 10 minutes. After incubation, 200 μl ethanol was added and vortexed for 15 seconds. 
Then the mixture was transferred to mini spin column and centrifuged at 6000 × g for 1 
minute at room temperature. The column was located on new 2 ml collection tube. 500 
μl Buffer AW1 was added and centrifuged at 6000 × g for 1 minute at room temperature. 
The column was located on new 2 ml collection tube. 500 μl Buffer AW2 was added and 
centrifuged at 14000 × rpm for 3 minute at room temperature. The column was located 
on new 1.5 ml microcentrifuge tube and centrifuged at 15000 × rpm for 1 minute in order 
to eliminate remaining buffer. The column was located on new 1.5 ml microcentrifuge 
tube and 50 μl Buffer AE was added into the column. The sample was incubated at room 
temperature for 5 minutes then centrifuged at 6000 × g for 1 minute.  Concentration of 
the genomic DNA was measured using Thermo Fisher 2000 NanoDrop 
spectrophotometer. The sample was stored at +40C for further use. 
 
4.3.2. shRNA-specific Barcode PCR Amplification 
 
To determine shRNA barcodes in monoclones, PCR performed with primer sets designed 
to amplify the barcode sides on genomic DNA of the samples (Table 4.1). Each 25 μl 
reaction included 50 ng gDNA of monoclones,10 µM dNTP, 0.5 μM primers, Taq 
polymerase, Taq polimeraz bufer and nuclease free water.   
 
Table 4.1 PCR reaction Primers 
Primer Name Sequence 
FwdHTS 5’-TTCTCTGGCAAGCAAAAGACGGCATA-3’ 
FwdU6-1 5’-CAAGGCTGTTAGAGAGATAATTGGAA-3’ 
FwdU6-2 5’-CCTAGTACAAAATACGTGACGTAGAA-3’ 
RevcPPT-5 5’-TGCCATTTGTCTCGAGGTCGAGAA-3’ 
RevHTS1 5’-TAGCCAACGCATCGCACAAGCCA-3’ 
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Table 4.2 PCR reaction Reagents 
Reaction Reagents Amount (µl) 
10X Taq polymerase buffer 2,5 
Forward primer 1 
Reverse primer 1 
dNTP (10 µM) 0,5 
gDNA 50ng Determined to each gDNA 
Taq polymerase 0,25 
Nuclease-free Water Up to 25 µl 
 
PCR was performed at 950C for 1 minute followed by 30 cycles of 950C 30 minutes, 550C 
30 minutes, 72°C 30 minutes. Final polymerase step was performed at 72°C 3 minutes.  
PCR products were stored at +40C for further use. 
Table 4.3 PCR reaction for Barcode amplification 
 
Cycle Time Temperature °C 
Initial Denaturation 1 1 minute 95 
Amplification 30 30 seconds 95 
  30 seconds 55 
  30 seconds 72 
Final polymerase 1 3 minutes 72 
 
4.3.3. Agarose Gel Electrophoresis 
1 gram of agarose powder was mixed with 50 ml 1X TAE buffer in a 100 ml 
microwavable flask for the preparation of 2% agarose gel. The flask was then placed into 
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the microwave until the agarose powder disolved completely in the buffer. The solution 
then left at room temperature for cooling. Mixture was poured carefully without making 
bubbles into a clean gel tray and comb was placed on the tray. Gel was stayed to dry for 
20-30 minutes at room temperature. After the gel began to polimeraze, it solidified. Dried 
gel was placed in the electrophoresis tank filled with 1X TAE buffer. 20 μl samples were 
prepared by mixing 4 μl 6X DNA loading dye. In first well, molecular weight DNA ladder 
was loaded and each sample were loaded. The gel was run at 100 Volt constant voltage 
for 30 minutes. After running, the gel was placed and incubated for 20 minutes into 100 
ml 1X TAE buffer containing 5 μl of ethidium bromide. After EtBr incubation, the gel 
was rinsed with water. DNA bands were visualized under UV-light. 
 
4.3.4. Purification of PCR Products 
PCR products were run on 2% agarose gel and the fragments were visualized under low 
exposed UV-light. DNA fragments were isolated from the gel by using bistoury. The 
isolated fragment was weighted in 1.5 ml microcentrifuge tubes. DNA fragments were 
purified by using QIAquick PCR purification kit according to the manufacturer's 
instructions. Briefly, 200 µl Bufer NTI was added in the tube containing DNA fragment 
and incubated at 50 0C for 10 minutes. The mixture was vortexed each 3 minutes. 
QIAquick PCR purification kit column was placed in 2 ml collection tubes.Then melted 
gel sample was transferred into columns and centrifuged at 11000 × g for 30 seconds for 
DNA binding on silica membrane. 700 µl Buffer NT3 was added to the column for 
cleaning of the membrane. The liquid collected in the tube was discarded and column was 
centrifuged one more time at 11000 × g for 1 minute in order to eliminate remaining 
buffer. Then column was placed on clean 1.5 ml microcentrifuge tube. 20 µl Buffer NE 
was added and the column was incubated 1 minute at room temperature. Then the column 
was centrifuged at 11000 × g for 1 minutes. Concentration of the purified DNA was 
measured by using ThermoFisher 2000 NanoDrop spectrophotometer. Samples were sent 
to BMLabosis (Turkey) for Sanger sequence analysis.  
 
4.3.5.  Target Gene Identification 
DECIPHERTM barcoded shRNA library, Mouse Module 1 (Cellecta): Pathway Targets, 
includes 27,500 shRNAs with 4,625 genes. Manufacturer provides a document including 
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target mRNA RefSeq# and HUGO gene symbol. Barcode sequences were searched at the 
document included HUGO Gene Symbol and RefSeq. 
 
Figure 4.1. Cellecta Decipher shRNA Library document. Barcode sequence site was 
highlighted and indicated with an arrow. 
4.4. Measurement of Targets’ mRNA level by RT-q-PCR 
 
4.4.1. RNA Isolation 
 
In order to determine the amount of TRPV6 and RAB23 mRNA level in monoclones 
RNA isolation was applied as following. MEF GFP-LC3 monoclones were seeded in 6 
well culture plates as 1x106 cell/well. Next day cells were treated with 0.006% DMSO as 
vehicle control and 100nm PMA for 30 minutes, EBSS and EBSS with 100nm PMA for 
2 hours. After the treatment procedure, cells were washed with 2 ml 1X PBS. RNA 
extraction was conducted by using Genezol RNA isolation reagent. 1 ml Genezol RNA 
reagent was put on the cells for lyses and incubated for 5 minutes at room temperature. 
Cell lysate was collected into 1,5 ml microcentrifuge tube and 200 µl chloroform was 
added. The mixture was up&down for 15 seconds to mix homogenously. The color 
change was observed from pink to pale pinkish after mixing. The solution was incubated 
15 minutes at room temperature. After incubation, the tube was centrifuged at 12000 × g 
for 10 minutes at room temperature. The phase separation was observed respectively 
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upper colorless, middle white line and bottom pink. The upper phase was carefully 
transferred into clean 1,5 ml microcentrifuge tube with avoiding touch to white phase. 
500 μl ice-cold 2-isopropanol was added on the colorless phase and incubated on ice for 
15 minutes. After incubation, the tube was centrifuged at 12000 × g for 10 minutes at 
+40C. Then supernatant was discarded, and 1 ml 75% ethanol was added onto the pellet. 
The mixture was centrifuged at 12000 × g for 10 minutes at +40C. Supernatant was 
discarded, and the pellet was incubated at room temperature for 20-30 minutes in order 
to eliminate ethanol. RNA pellets were dissolved in RNase free water by gently pipettage. 
Concentration of the RNA samples was measured using Thermo Fisher 2000 NanoDrop 
spectrophotometer and stored at -80 0C for further use. 
 
4.4.2. cDNA Synthesis 
 
cDNA was synthesized from 1000 ng RNA samples by reverse transcription PCR. First 
Dnase cycle was applied at 370C for 30 minutes. Then, EDTA cycle was applied for 750C 
for 10 minutes. Then, 10 µl PCR master mix including 5X reaction buffer, 10 mM dNTP, 
random hexamer (10 ng/µl), ribolock (40U/ µl), RT enzyme (200U/ µl) , nuclease-free 
water were added to EDTA cycle product. The cycles at 25 °C 10 minutes, 37 °C 60 
minutes and 70 °C 10 minutes were applied 3 times. At the end of cycles, PCR reaction 
was stoped by incubating PCR products on ice for 1-2 minutes. The samples were stored 
at -20 0C for further analysis. The reagents and the process for cDNA synyhesis are stated 
as tables at the below.  
Table 4.4 DNase Cycle Reagents 
Reagents Amount (µl) 
1000 ng RNA 7 
10X DNase I Buffer 1 
DNase I enzyme 1 
 
 
28 
 
Table 4.5 EDTA Cycle Reagents  
Reagents Amount (µl) 
DNase cycle product 9 
25 mM EDTA 1 
 
 
Table 4.6 Reverse transcription PCR (RT-PCR) Reagents 
Reagents Amount (µl) 
EDTA cycle product 10 
Nuclease-free Water 3,2 
5X reaction buffer 4 
10 mM dNTP 0,5 
Random hexamer (10 ng/µl) 0,2 
Ribolock (40U/ µl) 0,2 
RT enzyme 0,1 
 
4.4.3. RT-q-PCR 
 
mRNA expression level of target genes upon PMA and starvation treatment was analyzed 
with Quantitative Real-Time PCR reaction. cDNA samples were diluted 1:5 ratio with PCR 
grade water and 5 μl of the dilution was used as templete in RT-qPCT analysis.  0,5 μl 10 μM 
forward and 0.5 μl 10 μM reverse primers, 4 μl water and 10 μl 2x Sybr Green was added in 
a well of white 96 well plate on ice with dark condition. The 96 well plate was sealed with 
colorles sealer and centrifuged at 1500 × g for 2 minutes. β-glyceraldehyde 3-fosfat 
dehydrogenase (GAPDH) was houskeeping gene used as control. The reaction began with 
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1 cycle preincubation at 95 °C for 10 minutes and followed 50 cycle amplification at 95 °C 
for 10 secs, 60 °C for 1 minute and 72°C for 10 seconds, 1 cycle melting curve at 95 °C for 
5 seconds, 55 °C for 1 minute and 97 °C continuous and 1 cycle cooling at 40 °C for 30 
seconds. Results were analysed by ΔΔCT method. 
Table 4.7 List of RT-qPCR Primers 
Primer Name Sequence 
Mouse Forward TRPV6 5′- TTGGGCTGGTGCAATGTCA-3′ 
Mouse Reverse TRPV6 5′-AGCCAGCAGAATCGCATCAAG-3′ 
Mouse Forward RAB23 5′-AAAATGAGGAAGCGGAGGGA-3′ 
Mouse Reverse RAB23 5′-AGTGACTTCTGACCGATGCA-3′ 
Mouse Forward GAPDH 5′-TCACCACCATGGAGAAGGC-3′ 
Mouse Reverse GAPDH 5′- GCTAAGCAGTTGGTGGTGCA-3′ 
 
Table 4.8 RT-q-PCR Reagents 
Reagents Amount (µl) 
1:5 diluted cDNA 5 
10 μM Forward Primer 0,5 
10 μM Reverse Primer 0,5 
PCR Grade Water 4 
2x Sybr Green Master Mix 10 
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Table 4.9 RT-q-PCR reaction 
Cycle Time Temperature °C 
Pre-incubation 1 95 
Amplification 50 95 
  
60 
  
72 
Melting Curve 1 95 
  
55 
  
97 
Cooling 1 40 
 
4.5. LC3 Dot Analysis 
 
HeLa LC3 stable cells were seeded on coverslips in the 6 well-plates as 1,25 x 105 
cell/well and MEF GFP-LC3 transgenic cells were seeded in 12 well-plates as 2 x 104 
cell/well. After 36 hours, corresponding wells were treated with EBSS for 2 hours. In the 
last 30 minutes of EBSS, 100 nM PMA and the necessary amount of DMSO were added 
to the media. Cells were fixed with 4% paraformaldehyde for 20 minutes on ice and 
mounted on the slides. Minimum 100 cells were counted for each sample under 60x 
magnification on Olympus BX60 fluorescence microscope and thresholds were 
determined as > 20 dots for HeLa LC3 stable cells and > 8 dots for MEF GFP-LC3 
transgenic cells, respectively. Threshold number of LC3 puncta were determined in 
vehicle control group. Cells having LC3 puncta more than threshold number were 
counted as positive autophagic cells and cells having LC3 puncta less than threshold 
number were counted as negative autophagic cells. 
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4.6. Cell Lysate Preparation and Immunoblotting 
 
Cells were lysed with RIPA buffer containing 1% complete protease inhibitors and 1 mM 
PMSF. The lysed was incubated on ice for 20 minutes and every 5 minutes it was mixed 
by vortexing. Then the lysed was centrifuged for 15 minutes at 13200 rpm, 40C. After 
centrifugation, the supernatant was taken into new tube and protein concentration was 
determined by Bradford Assay. For immunoblotting, 40 µg proteins were denatered in 
3X protein loading dye for 10 minutes at 950C. Denatured proteins were loaded to the 
SDS-Polyacrylamide (PAGE) gels (Table 4.11 and 4.12) and separated using 15% gel for 
LC3 and 10% gel for other proteins. Proteins were transferred to nitrocellulose 
membranes at 250 mA for 1 hour for LC3 and 1 hours 15 minutes for other proteins. 
Membranes were blocked in 5% non-fat milk in PBS-T for 1 hour at room temperature 
and washed with PBS. Then membranes were incubated with primary antibodies diluted 
in red solution with 1:1000 ratio for 1 hour at room temperature or overnight at 40C then 
washed with PBS-T three times at each 5 minutes. After washing, the membranes were 
incubated with secondary antibodies prepared in 5% non-fat milk solution with 1:10000 
ratio for 1 hour at room temperature and rinsed with PBS-T three times at each 5 minutes. 
Then membrane was placed on cassettes and signals were displayed by 
chemiluminescence reagent or homemade ECL solution. After observing signals, films 
were placed on membranes and the cassettes were closed and stored in dark for at least 
20 minutes. Then the films were developed and fixed by using developer and fixer 
solutions until the bands arise. The band intensities were analyzed with ImageJ software. 
Table 4.10 SDS- PAGE Separating gel preparation 
Lower Gel 15% 10% 
 5 ml 10 ml 20 ml 5 ml 10 ml 20 ml 
ddH2O 850 μl 1.75 ml 3.5 ml 1.7 ml 3.4 ml 6.8 ml 
50 % Glycerol 400 μl 750 μl 1.5 ml 400 μl 750 μl 1.5 ml 
Lower Buffer 1.25 ml 2.5 ml 5ml 1.25 ml 2.5 ml 5ml 
Bis/Acrylamide 2.5 ml 5 ml 10 ml 1.65 ml 3.35 ml 6.7 ml 
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10% APS 50 μl 100 μl 200μl 50 μl 100 μl 200μl 
Temed 5 μl 10 μl 20μl 5 μl 10 μl 20μl 
 
Table 4.11 SDS- PAGE Stacking gel preparation 
Upper Gel 2.5 ml 5 ml 7.5 ml 12.5 ml 
ddH2O 1.62 ml 3.25 ml 4.88 ml 8.13 ml 
Upper Buffer 625 μl 1.25 ml 1.87 ml 3.12 ml 
Bis/Acrylamide 250 μl 500 μl 750 μl 1.25 ml 
10% APS 20 μl 40 μl 60 μl 100 μl 
Temed 5 μl 10 μl 15 μl 25 μl 
 
 
4.7. Prediction of Protein-Protein Interaction of Target Protein and PKC by 
Bioinformatics-Based Software 
 
Based on the findings indicating the presence of interaction between TRPV6 or RAB23 
with PKCs, a preliminary analysis based entirely on amino acid sequence information 
was performed to give an idea of the regions through which this interaction could be 
achieved. For this purpose, bioinformatics tools, GPS 2.0, Phosphomotif, DISPHOS, 
KinasePhos2.0, NetPhos 3.1, NetPhorest, PKIS, PhosphoPick, and Muside, were used.  
 
4.8. HeLa Cell Line Transfection Protocols 
 
4.8.1. Transfection with Calcium-Phosphate  
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HeLa cells were seeded to 6-well plates as 150 000 cell/well. Next day, cells were 
transfected with 4 µg of pcDNA3.1 for control, pMAX GFP for transfection control by 
using Calcium-Phosphate Transfection. The total volume of plasmid mixture was 
completed to 54 µl with Hyclone water and 6 µl 2.5 M CaCl2 was added. This mixture 
was added onto 60 µl of 2xHBS drop by drop with continuous vortex. After 20 minutes 
of incubation, the solution was distributed to well as 120 µl. 8 hours after post 
transfection, cells were washed with 1x PBS twice and 2 ml complete medium added. 
 
4.8.2. Amaxa Nucleofactor Transfection  
 
HeLa cells are homogenized and counted with Trypan blue. 225 000 cell/well were transfered 
to eppendorfs and centrifuged at 3000 × g for 5 minutes Nucleofactor reagents were mixed 
with 4.5:1 nucleofactor to supplement ratio. Supernatant was discarded and cells were 
resuspended in 90 μL nucleofactor mixture including 4 ug pMAX GFP. Mixture is taken to 
cuvette and electroporated with AMAXA machine. After incubation for 10 minutes, cells 
were mixed with medium. Then they were seeded to 6 well plates. 8 hours after post 
transfection, cells were washed with 1x PBS twice and 2 ml complete medium added. 
 
4.8.3. Lipofectamine Transfection 
 
HeLa cells were seeded to 6-well plates as 125 000 cell/well. Next day, cells were 
transfected with 6 µg of pcDNA3.1 for control or pMAX GFP for transfection control by 
using Lipofectamine 2000. 6 µg of plasmids were mixed with 100 µL OptiMEM 
separately. The optimum ratio of DNA to Lipofectamine is ½ for HeLa cells. In another 
eppendorf tube, 12 µL Lipofectamine was mixed with 200 µL OptiMEM. The solutions 
were allowed for incubation for 5 min at RT.  Then mixture with DNA were added on top 
of tube including Lipofectamine-OptiMEM. The solution was vortexed and incubated for 
15 minutes at RT and vortexed each 5 minutes. During incubation process, cells were 
washed with 1X PBS once. After washing, 800 µL OptiMEM were given to each well. 
After incubation, Lipofectamine-plasmid solution was added to wells. After 4 hours from 
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post transfection, cells were washed with 1X PBS twice then 2 mL complete medium 
added.  
4.8.4. Polyethyleneimine Transfection 
 
HeLa cells were seeded to 6-well plates as 125 000 cell/well. Next day, cells were 
transfected with 4 µg of pcDNA3.1 for control or pMAX GFP for transfection control by 
using PEI. In one tube, 100 µL only DMEM mixed with 9 µL PEI. In another tube, 100 
µL only DMEM mixed with 4 µg plasmid DNA. Then PEI-DMEM mixture was added 
drop by drop into plasmid-DMEM mixture on vortex. The solution was incubated for 15 
minutes at RT. Cells were washed with 1X PBS ones and 2 ml complete medium added. 
After incubation solution was given to cells and 8 hours later the cells were washed with 
1X PBS twice and complete medium added.  
4.8.5. FuGENE Transfection 
 
FuGENE 6 Transfection Reagent was used according to the manufacturer's instructions. 
Briefly, HeLa cells were split in 6-well plates as 150000 cells/well. Next day, FuGENE 
transfection was performed with 4 µg of pcDNA3.1 as control and pMAX-GFP for 
transfection control. In microcentrifuge tubes, pcDNA3.1 or pMAX-GFP was mixed with 
90 μl OptiMEM then FuGENE 6 reagent was added to DNA-OptiMEM mixture as 3:1 
ratio (FuGENE 6 Reagent (µl): DNA (µg)). The transfection reagent with DNA mixture 
was vortexed and incubated for 15 minutes at room temperature. Media of the cells was 
replaced with OptiMEM. After incubation, the mixture was given to cells drop by drop. 
8 hours later, the cells were washed with 1X PBS and fresh media was added.  
 
4.9. Flow Cytometry 
 
For transfection efficiency check, flow cytometry protocol was applied. The cells were 
washed with 1X PBS and detached with trypsin. Detached cells were resuspended in 1 
ml PBS including 10% FBS and centrifuged at 300 g for 5 minutes. Then pellets were 
resuspended in 200 µl PBS including 10% FBS and transferred into FACS tubes.  
35 
 
Cells were analysed with BD FACSCanto II flow cytometry system with green laser. 
Flourescence measurements were blank corrected with the fluorescence signals of non-
transfected cells (20000 cells/ flow) and normalized with the same number of cells.  
 
 
 
Figure 4.2. Representation of target gene including barcode sequence and shRNA region 
 
 
Figure 4.3. Lentivirus transduction and singe cell monoclone production 
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5. RESULTS 
 
5.1. Autophagy is inhibited by PMA treatment in MEF GFP-LC3 cells  
 
PMA is a synthetic drug that has structural and functional similarities with diacyl 
glycerol. Because of these characteristics, it is generally used as an activator of novel 
PKC isozymes in molecular biology. Previously, we showed that the stimulation of PKC 
isozymes by PMA treatment causes an alteration in autophagy regulation compared to 
basal condition. In order to confirm the effect of PMA in autophagy, we performed GFP-
LC3 analysis.  
GFP-LC3 dot counting is common technique used for visualization of autophagy 
activation under different conditions. Green dots in the cytosol represent the 
autophagosome-associated LC3-II formation. When MEF GFP-LC3 transgenic cells 
were treated with PMA, the number of GFP-LC3 dot formation was decreased compared 
to control group. Under starvation condition, autophagy is upregulated in order to 
maintain cellular homeostasis. The number of LC3-II dots was higher in starved cells, 
while lower in PMA group compared to control. The effect of PMA was confirmed by 
combined treatment with starvation media. PMA with starvation showed significant 
decrease in the number of LC3 puncta compared to starvation. Accordingly, autophagy 
activation is suppressed under PMA exposure in MEF GFP-LC3 cells, both in basal and 
starvation-induced conditions.  
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Figure 5.1. GFP-LC3 dot formation upon PMA and starvation treatment. (A.) Cells were 
treated with DMSO or PMA (100 nM) for 30 minutes and EBSS for 2 hours. Microscopic 
images were visualized under fluorescence microscopy with 60x objective (B.) 
Quantification of GFP-LC3 positive cells. Percentage of positive cells in total counted 
cells (minimum 100 cells) were compared in the graph. DMSO was used as a vehicle 
control of PMA. Data were shown as mean ± SD of independent experiments, n=3. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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5.2. Autophagy is induced by PKC activation with Ceramide treatment in MEF 
GFP-LC3 cells  
 
Ceramide is commonly used as a secondary messenger in order to activate atypical PKCζ. 
Previously, we found that the atypical PKCζ promotes autophagy. In order to confirm 
previous data we performed autophagy analysis. Upon 1 µM Ceramide treatment for 30 
minutes, the number of LC3 dots were increased in basal condition.  
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Figure 5.2. GFP-LC3 dot formation upon Ceramide and starvation treatment. (A.) Cells 
were treated with DMSO or ceramide (1 µM) for 30 minutes and EBSS for 2 hours. 
Microscopic images were visualized under fluorescence microscopy with 60x objective 
(B.) Quantification of GFP-LC3 positive cells. Percentage of positive cells in total 
counted cells (minimum 100 cells) were compared in the graph. DMSO was used as a 
vehicle control of ceramide. Data were shown as mean ± SD of independent experiments, 
n=3. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
5.3. Lentivirus Transduction to MEF GFP-LC3 transgenic cells  
 
In the previous part, the alterations in autophagy mechanism were demonstrated under 
PMA, ceramide and starvation-treated conditions. In order to investigate the relationship 
of PKC isozymes and their targets in the signaling pathways related to autophagy 
mechanism, shRNA lentiviral pool infection was performed in MEF GFP-LC3 transgenic 
cells. shRNA lentiviral pool is a pathway target specific lentivirus mixture containing 
more than 27000 vectors targeting 4625 genes. Our first aim was to produce lentiviral 
vectors in HEK293T cells and followed by infection of MEF GFP-LC3 transgenic cells 
with produced lentivirus pool. Since the final goal was to identify specific targets related 
with PKC isozymes and their effect on autophagy mechanism, monoclonal cells were 
generated. 
HEK293T cells were transduced with shRNA lentiviral library with calcium phosphate 
transfection protocol. RFP shRNA control lentiviral vector was used as an empty control. 
Both helper and envelope plasmids were used in combination with shRNA lentivirus to 
increase efficiency of virus production in the cells. The ratio of vectors was 5 lentivirus 
pool; 1 envelop vector pmD2.G; 4 helper vector psPAX2. After transduction of HEK293T 
cells, the virus titers were collected at 36 and 48 hours. After filteration, MEF GFP-LC3 
transgenic cells were transduced with 0, 50, 100, 250 and 500 μl of shRNA lentiviral 
library or RFP shRNA control vector. 50 μl lentivirus group has lower RFP signals so 
their propagation might be difficult under antibiotic selection. On the other hand, almost 
each cell in 250 and 500 μl lentivirus groups have RFP signal so it was suspected that the 
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cells might have more than one lentivirus infection. We aimed to give one vector to each 
cell so 250 and 500 μl lentivirus groups were eliminated. The RFP signal ratio in 100 μl 
lentivirus group was moderate compared to others so we choose to continue antibiotic 
selection by using this titration (Figure 5.3). 
Transduced cells including puromycin resistance gene were subjected to puromycin 
treatment for 10 days in order to produce monoclonal cells. The cells without lentiviral 
vectors died in 2 days while propagation of transduced cells increased.  
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Figure 5.3. Transduction efficiency with different virus titers.  
 
5.4. The effect of PMA and Ceramide treatment on monoclones 
 
After puromycin selection, transduced cells were diluted and seeded in 96 well culture plate. Each 
well was checked under fluorescence microscopy with green and red channels. The wells including 
single cell were determined and labelled to follow the further colony growth. 12 monoclones 
including shRNA lentiviral library and 10 monoclones including RFP shRNA control vector were 
labelled in 96 well plates, however, half of them died during propagation processes. When each 
single colony covered 80% of  wells, they were transferred to 24 well plate, 12 well plate, 6 well 
plate and 10 cm culture plate respectively. After growing in 10 cm plate, they were divided into two 
as one for propagation in order to use for further analysis; one for barcode sequence analysis. Total 
6 monoclones having shRNA lentiviral library vector and 3 monoclones having RFP shRNA 
control vector were produced.  
To determine the change in autophagy mechanism after PMA and ceramide treatment, GFP-LC3 
puncta count was performed by using each monoclones. It was interesting that autophagic activity 
was upregulated in some monoclones upon PMA treatment. As indicated in the first section, PMA 
had inhibitory effect on autophagy in MEF GFP-LC3 transgenic cells. Reverse result of PMA 
treatment in single cell monoclones supports our hypothesis, that downregulation of specific gene 
by shRNA causes change in autophagy activation. Especially, MC3 monoclone showed significant 
increase in autophagy under PMA treatment compared to basal condition (Figure 5.4 A). The 
downregulation of specific gene in MC3 clone may cause the impairment of autophagy under PKC 
activation. 
Although ceramide treatment induced autophagy in MEF GFP-LC3 transgenic cells 
indicated as control in Figure 5.4, MC6 single cell monoclone suppressed autophagy upon 
ceramide treatment in both basal and starvation-induced condition (Figure 5.4 B). This 
result showed that the decrease in LC3 puncta formation may be due to inhibition of target 
gene in MC6 monoclone by shRNA.  
As expected, starvation condition caused the significant increase in the number of LC3 
dots in monoclones. GFP-LC3 dot formation in monoclones was shown in Figure 5.5.  
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Figure 5.4. GFP-LC3 puncta count upon (A.) PMA and (B.) ceramide treatment in 
monoclones. DMSO was used as a vehicle control of PMA and ceramide. Control group 
was results of non-transfected MEF GFP-LC3 cells. Data were shown as mean ± SD of 
independent experiments, n=3. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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Figure 5.5. GFP-LC3 puncta images upon PMA and ceramide treatment of single cell 
monoclones under fluorescence microscopy with 60x objective. DMSO was used as a 
vehicle control of PMA and ceramide. 
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5.5. Monoclones’s Sequence Result 
 
Six different single clones were propagated and their barcode sequence in genomic DNA were 
amplified with PCR. Four different primer pairs were used in order to amplify barcode sequence or 
barcode with shRNA sequence. Barcode sequence amplification was represented at Figure 5.6 part 
A.   
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Figure 5.6. Barcode sequence amplification (A.) Representation of primer, barcode and 
shRNA sites of vector. (B.) Maps of lentivirus plasmids.  
PCR products were visualized on agarose gel in order to check the fragment of interest. Forward 
U61-Reverse PPT5 primer pairs and Forward U62-Reverse PPT5 primer pair amplified both 
shRNA and barcode sequence together. However, it was observed that this primer pairs also 
amplified non-specific sequences in genomic DNA of monoclones including RFP shRNA control 
vector (RC) (Figure 5.7 A-B). The primer pairs were not appropriate for barcode amplification 
because they were not site specific for shRNA and barcode regions. Forward HTS2-Reverse HTS1 
and Forward HTS2-Reverse PPT5 primer pairs were used for only barcode sequence amplification. 
However, as previous primer pairs, non-specific sequences in genomic DNA of monoclones 
including RFP shRNA control vector were amplified with Forward HTS2-Reverse HTS1 primer 
pair (Figure 5.7 C). Meaning that, the primer pair was not specific for barcode sequence 
amplification. Forward HTS2-Reverse PPT5 primer pair amplified only barcode sequence in 
monoclones having shRNA and they did not amplify any region in genomic DNA of monoclones 
including RFP shRNA control vector (Figure 5.7 D).  
Agarose gel images showed that only PCR reaction with Forward HTS2 and Reverse PPT5 primer 
pair gave the correct fragments in monoclones including lentivirus library, but not monoclones 
including RFP shRNA control vector. PCR products were purified from agarose gel and sent to 
sequence analysis in order to determine corresponding gene of interest.   
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Figure 5.7. Agarose gel images of PCR amplification in monoclones. (A.) PCR product 
of monoclones amplified with Forward U61-Reverse PPT5 primer pairs. (B.) Forward 
U62-Reverse PPT5 primer pair. (C.) Forward HTS2-Reverse HTS1 primer pair. (D.) 
Forward HTS2-Reverse PPT5 primer pair. RC clones were used as negative control, 
which include only RFP shRNA control vector and did not contain any barcode sequence. 
 
According to the DNA sequence data (Figure 5.8), MC3 monoclone has barcode sequence 
specific for TRPV6 gene and MC10 monoclone has barcode sequence specific for Rab 
23 gene (Table 5.1.).   
 
Figure 5.8. Barcode Sites of monoclones was highlighted at Cellecta shRNA Library 
document 
 
Table5.1. Sequence Result 
Monoclone NM code Hugo gene symbol 18-nt- Barcode 
MC 10 NM_008999.3 Rab23 CAGTTGACTGGTACTGAC 
MC 3 NM_022413.3 Trpv6 CAGTACGTCAACACGTAC 
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5.6 TRPV6 gene expression and protein level were examined in MC3 monoclone 
 
In order to confirm gene silencing, mRNA expression of TRPV6 under PMA and 
starvation treatments in MEF GFP-LC3 transgenic cells and MC3 monoclone was 
examined by RT-q- PCR analysis. Under basal condition mRNA level of TRPV6 in MC3 
is significantly lower than MEF GFP-LC3 cells (Figure 5.9 A).  
p62 is a receptor for ubiquitinated proteins and directed them to the autophagic 
degradation. p62 is degraded by autophagy so the decrease in p62 indicates autophagic 
activity. Increased level of autophagosome-associated LC3 I and increased level of p62 
in MEF GFP-LC3 transgenic cells confirmed inhibitory effect of PMA on autophagy 
(Figure 5.9 B)  
While mRNA level of target protein was significantly lower, there was not prominent 
change in the target protein level in MEF GFP-LC3 transgenic and MC3 monoclones 
(Figure 5.9 B-C). Under PMA treatment PKCδ expression increased in both basal and 
starvation-induced condition in MEF GFP-LC3 transgenic and MC3 monoclones (Figure 
5.9 B-C). These results indicated that downregulation of TRPV6 gene could be a target 
of PKCδ that regulate autophagy. 
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Figure 5.9. Confirmation of gene silencing of TRPV6 and its effect on autophagy in MEF 
GFP-LC3 transgenic cells (A and B) and MC3 monoclone (A and C) under PMA and 
starvation-induced conditions. (B and C) Immunoblots showing protein expression of 
PKCδ, TRPV6, p62 and LC3. Cells were treated with DMSO or PMA (100nM) for 30 
minutes and EBSS for 2 hours. ACTB was used as a loading control.  Data were shown 
as mean ± SD of independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. 
 
5.7 RAB23 gene expression and protein level were examined in single cell clone 
 
RAB23 gene was the silenced gene according to barcode sequence analysis in MC10. 
However, mRNA expression of RAB23 in MC10 was not lower than MEF GFP-LC3 
cells (Figure 5.10 A).  Maybe the sequence result or primer pairs in RT-q-PCR were not 
completely specific for RAB23. However, it is interesting that under PMA treatment, p62 
level was decreased compared to non-starvation and starvation conditions in MC10 cells 
(Figure 5.10 C.).  
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Figure 5.10. Confirmation of gene silencing of RAB23 and its effect on autophagy in 
MEF GFP-LC3 transgenic cells (A and B) and MC10 monoclone (A and C) under PMA 
and starvation-induced conditions. (B and C) Immunoblots showing protein expression 
of p62 and LC3. Cells were treated with DMSO or PMA (100nM) for 30 minutes and 
EBSS for 2 hours. ACTB was used as a loading control.  Data were shown as mean ± SD 
of independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
 
5.8 Confirmation of the effect of PMA and expression of TRPV6 in HeLa GFP-
LC3 Stable Cells 
 
In the literature, the alteration of TRPV6 expression was detected in development and 
progression of prostate cancer, lung cancer, ovarian cancer and breast cancer (Haustrate, 
Hantute-Ghesquier, Prevarskaya, & Lehen’kyi, 2019; Kaemmerer, Turner, Peters, 
Roberts-Thomson, & Monteith, 2018; Lutes et al., 2018; Song et al., 2018). In the light 
of that, the interaction of TRPV6 with PKCδ and its effect on autophagy mechanism was 
aimed to investigate in HeLa GFP-LC3 stable cell line. However, HeLa GFP-LC3 cells 
could not be transfected by using conventional calcium phosphate (CaPO4) protocol. 
Therefore, first, transfection efficiency of several methods was analyzed at 48 h post 
transfection. 
 
Previously, calcium phosphate (CaPO4) transfection protocol was used for HeLa cell line 
transfection yet, pH of CaPO4 could not be stabilized. Transfection solutions with 
different pH groups were tested range from 7.00 to 7.20 and GFP signals were only 
detected at 7.10 and 7.13 pH value but with very low efficiency.  
 
In the literature, lipid or polymer-based transfection reagents such as Lipofectamine and 
FuGENE were mostly used for HeLa cell line transfection. Instead of CaPO4 transfection, 
we decided to check the transfection efficiency of electroporation, Lipofectamine 2000, 
FuGENE 6 or PEI reagents. The flow cytometry result showed that CaPO4 transfection 
had the lowest efficiency with 5%, while Amaxa Nucleofector transfection had the most 
efficient transfection with 96%, Lipofectamine 2000 had relatively good efficiency as 
70%, FuGENE 6 only transfected 17 % of cells and PEI transfected 5% of cells (Figure 
5.12). The cytotoxicity of transfection was also important because higher transfection 
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efficiency resulted in the decrease of viability. Although the initial number of cells were 
equal for each transfection group, most of cells died after Amaxa Nucleofector 
transfection compared to other groups. The rate of dead cells was the least in PEI and 
CaPO4 transfection groups however changes in cell shape were observed in CaPO4 
transfection groups. The cell death was moderate in Lipofectamine 2000 transfection, so 
we decided to continue further transfection experiments by using Lipofectamine 2000 
reagent.  
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Figure 5.11.  Fluorescent microscope images of different transfection methods in HeLa 
cells at 48 h post transfection. 
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Figure 5.12.  Evaluation of the transfection efficiencies of Amaxa Nucleofector, 
Lipofectamine 2000, FuGENE 6, PEI and CaPO4 protocols in HeLa cells. (A and C) 
Representative flow cytometry dot plots with percentage of GFP expressing cells. (B and 
D) Bar chart indicating the percentage of GFP-positive cells in HeLa cells transfected by 
Amaxa Nucleofector, Lipofectamine 2000, FuGENE 6, PEI and CaPO4. pcDNA3 empty 
vector was used as control.  
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Autophagy activity under PMA and starvation conditions was verified with GFP-LC3 dot 
counting and LC3 II formation (Figure 5.13 A-B) As shown previously, PMA induced 
PKCδ expression compared to vehicle control DMSO. TRPV6 expression was shown in 
HeLa GFP-LC3 cells and there was an increase in the TRPV6 expression upon PMA with 
starvation treatment (Figure 5.13 C). 
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Figure 5.13. The effect of PMA on autophagy in HeLa GFP-LC3 stable cells. (A.) GFP-
LC3 dot formation upon PMA and starvation treatment was observed under fluorescence 
microscopy with 60x objective (B.) Number of GFP-LC3 positive cells in each treatment 
groups were determined. (C.) Immunoblots showing protein expression of PKCδ, TRPV6 
and LC3. Cells were treated with DMSO or PMA (100nM) for 30 minutes and EBSS for 
2 hours. ACTB was used as a loading control.  Data were shown as mean ± SD of 
independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
5.9. The effect of overexpression of PKCδ on TRPV6 expression and Autophagy 
 
In order to check the relationship of PKCδ, TRPV6 and autophagy, the effect of PMA and 
starvation on TRPV6 expression as well as autophagy was investigated by PKCδ 
overexpression. PKCδ overexpression and PMA treatment caused the increase in the 
number of LC3 dots (Figure 5.14 A-B). Under PMA treatment, TRPV6 expression was 
increased compared to control, meanwhile the increase in the degradation of TRPV6 
under starvation was reversed with PMA with starvation treatment (Figure 5.14 C).   
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Figure 5.14.   The effect of PKCδ overexpression on autophagy in HeLa GFP-LC3 stable 
cells. (A.) GFP-LC3 dot formation upon PMA and starvation treatment was observed 
under fluorescence microscopy with 60x objective (B.) Number of GFP-LC3 positive 
cells in each treatment groups were determined. (C.) Immunoblots showing protein 
expression of PKCδ, TRPV6 and LC3. Cells were treated with DMSO or PMA (100nM) 
for 30 minutes and EBSS for 2 hours. ACTB was used as a loading control.  Data were 
shown as mean ± SD of independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. 
57 
 
5.10 The effect of PKCδ inhibition on TRPV6 and autophagy 
 
In previous part, it was shown that, the upregulation of PKCδ caused the increase in 
TRPV6 expression. We wondered whether knockdown of PKCδ by shRNA leads to any 
alteration in TRPV6 expression. Therefore, PKC delta expression was downregulated by 
shPKCδ transfection and both autophagy activation and TRPV6 expression were 
analyzed. While overexpression of PKCδ caused the increase in autophagy activation, 
shPKCδ knockdown led slight decrease in autophagy (Figure 5.15 A-B). It’s remarkable 
that, the level of TRPV6 was increased with under PKCδ downregulation compared to 
control and PKCδ overexpression.  
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Figure 5.15. The effect of shPKCδ on autophagy and TRPV6 expression in HeLa GFP-
LC3 stable cells. (A.) GFP-LC3 dot formation upon PMA and starvation treatment was 
observed under fluorescence microscopy with 60x objective (B.) Number of GFP-LC3 
positive cells in each treatment groups were determined. (C.) Immunoblots showing 
protein expression of PKCδ, TRPV6 and LC3. Cells were treated with DMSO or PMA 
(100nM) for 30 minutes and EBSS for 2 hours. ACTB was used as a loading control.  
Data were shown as mean ± SD of independent experiments, n=3, *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
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5. 11 Change in PKCδ and autophagy regulation under TRPV6 knockdown 
 
So far, we observed an interaction between TRPV6 and PKCδ and its effect on autophagy 
mechanism. To understand this interaction, PKCδ expression and autophagy regulation 
were analyzed under the suppression of TRPV6. It was shown that PKCδ expression 
could not change upon TRPV6 downregulation (Figure 5. 17 C). As in MC3 monoclone, 
PMA induced autophagy was observed in TRPV6 suppresed HeLa GFP-LC3 stable cells 
(Figure 5. 17 A-B). So that downregulation of TRPV6 caused the increase in autophagy 
activation.  
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Figure 5.16. The effect of control siRNA on autophagy in HeLa GFP-LC3 stable cells. 
(A.) GFP-LC3 dot formation upon PMA and starvation treatment was observed under 
fluorescence microscopy with 60x objective (B.) Number of GFP-LC3 positive cells in 
each treatment groups were determined. (C.) Immunoblots showing protein expression of 
PKCδ, TRPV6 and LC3. Cells were treated with DMSO or PMA (100nM) for 30 minutes 
and EBSS for 2 hours. ACTB was used as a loading control.  Data were shown as mean 
± SD of independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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Figure 5.17. The effect of siRPV6 on autophagy in HeLa GFP-LC3 stable cells. (A.) 
GFP-LC3 dot formation upon PMA and starvation treatment was observed under 
fluorescence microscopy with 60x objective (B.) Number of GFP-LC3 positive cells in 
each treatment groups were determined. (C.) Immunoblots showing protein expression of 
PKCδ, TRPV6 and LC3. Cells were treated with DMSO or PMA (100nM) for 30 minutes 
and EBSS for 2 hours. ACTB was used as a loading control.  Data were shown as mean 
± SD of independent experiments, n=3, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
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5.12 Possible Phosphorylation Sites on TRPV6 and RAB23 by PKCδ 
 
In the literature it was reported that TRPV6 has PKC isozymes mediated phosphorylation 
sites [86]. In the light of these data, possible phosphorylation sites were predicted by using 
nine different bioinformatics tools. Accordingly, hit regions that may play a role in the 
interaction between TRPV6 and PKCδ were shown in Table 5.1. Also, the possible 
phosphorylation sites on RAB23 by PKCδ were indicated in Table 5.2. Consequently, it 
was observed that the middle and carboxyl end domains of targets protein may be 
important for this interaction. 
 
Table 5.2 Predicted Phosphorylation sites of TRPV6 by PKCδ 
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Table 5.3 Predicted Phosphorylation sites of RAB23 by PKCδ 
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6. DISCUSSION  
 
Protein kinase C (PKC) isozymes are members of the Serine/Threonine kinase family 
regulating cellular events through the activation of various signaling pathways. These 
pathways involve in cell proliferation, development, cellular survival and death 
mechanisms. It was shown that some PKC isozymes affect autophagy; yet, the exact 
mechanism of the relationship between PKC isozymes and autophagy is not clearly 
identified. In this regard, our former group members worked on the identification of PKC 
isozymes that take place in the autophagy regulation under PKC activators and starvation 
induced conditions in HeLa cells. Protein level of each PKC isozymes and autophagy 
activation were examined under PMA, ionomycin and ceramide conditions.  According 
to their data, under PMA treatment which is novel PKC activator, autophagy regulation 
was suppressed. When they checked the protein level and phosphorylation of PKC 
isozymes on activation sites, they found specifically increased protein expression and 
phosphorylation of PKCδ. Also, under ceramide treatment they showed the increase in 
the autophagy compared to basal condition. Thus, in this thesis, we aimed to identify a 
novel protein associated with PKC isozymes in the fate of autophagy regulation by 
shRNA-based gene silencing.   
Phosphorylation of LC3 by PKC was found, however the role of phosphorylation on 
autophagy could not be identified after mutagenesis on phosphorylation sites. This is 
because the endogenous expression of LC3 was enough to regulate autophagy albeit of 
mutant LC3 proteins (Jiang, Cheng, Liu, Peng, & Feng, 2010). Also, ULK1 
phosphorylation by PKC influenced autophagosome formation negatively because of 
increasing CMA activity in order to recycle phosphorylated ULK1 proteins (C. Wang et 
al., 2018).  PKCδ activity resulted in the attenuation of autophagy while increasing 
apoptosis in order to protect kidney cells from cisplatin induced nephrotoxicity. The 
mechanism occurs due to phosphorylation of AKT and activation of mTOR by PKCδ 
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(Dongshan Zhang et al., 2017a). Interaction of AKT/mTOR/ULK1 complex with PKC 
was found important for initiation of autophagy whereas LC3 phosphorylation crucial for 
autophagosome formation and elongation. Under hypoxic stress, calcium storages in ER 
were released and caused Ca+2 dependent PKCθ activation. PKCθ signaling resulted in 
the increase in autophagy regulation in hepatic stellate cells (Jin et al., 2016). In another 
study, critical role of PKCδ in autophagy and apoptosis under hypoxic stress was 
demonstrated. While under short term stress condition, PKCδ caused the increase in 
autophagy to protect cells from death, under long term stress PKCδ initiated apoptosis in 
order to get rid of nonfunctional damaged cells to protect environment (J.-L. Chen et al., 
2009; Liu et al., 2019; So & Oh, 2016). Noticeably, PKC signaling has pivotal role in the 
regulation of autophagy to decide cells’ destiny under stress conditions. Thus, 
investigation of PKC signaling pathways is important to understand the cell death and 
survival mechanisms in a broader perspective.  
In relation to the data, we have previously obtained, in this thesis, it was crucial to show 
the effect of PKCδ activation on autophagy mechanism in MEF GFP-LC3 transgenic cells 
upon PMA treatment. PMA showed an inhibitory effect on autophagy consistent with our 
previous results (Figure 5.1). Ceramide is a specific drug used for the activation of PKCζ. 
PKCζ is another PKC isozyme that could possibly has function in autophagy regulation, 
since we showed the change in autophagy activation under ceramide treatment (Figure 
5.2).   
For further analysis, MEF GFP-LC3 transgenic cells were infected with lentiviral shRNA 
library, that includes 4625 shRNA targeting genes having role in different signaling 
pathways. After successful selection with puromycin treatment, monoclonal cells were 
produced. During monoclone propagation and maintenance, half of them were died. 
Probably in those monoclones, crucial cell survival genes were silenced so they could not 
be propagated. Also, the growth rate and cell size were changed after infection in most of 
monoclones. They grew slower and had smaller surface area compared to non-transduced 
cells. To determine the change in PMA or ceramide-dependent autophagy, GFP-LC3 
puncta count was performed in each monoclones. MC3 monoclone had significant 
autophagy activation upon PMA treatment under both basal and starvation-induced 
conditions. This result is significant because PMA had an inhibitory effect on autophagy 
regulation in non-transduced cells. According to the sequence analysis, the suppressed 
gene in MC3 monoclone was TRPV6 which is one of the transmembrane calcium 
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channels. mRNA expression of TRPV6 showed the successful inhibition of target gene 
by lentiviral shRNA in MC3 monoclone. Previously, PMA treatment showed the 
inhibition of autophagy in non-transduced MEF GFP-LC3 transgenic cells. However, it 
was reverse in MC3 monoclone, therefore PMA-induced autophagy might be blocked 
due to suppression of TRPV6 (Figure 5.9).  
TRPV6 is a member of transient receptor potential superfamily and located on both 
endoplasmic reticulum (ER) and cell membrane. TRPV6 channels are highly sensitive to 
intracellular Ca+2 concentration and acts either homotetrameric or heterotetrameric 
structure with TRPV5. An increase in Ca+2 level results in the inactivation of TRPV6 
function via the PLC-PIP2 signaling pathway (Haustrate et al., 2019). The change in 
expression of TRPV6 was demonstrated in several disease progressions such as 
carcinogenesis, kidney and cardiac failure due to the disruption of Ca+2 uptake (Humeau 
et al., 2018). Calcium is an essential secondary messenger in signal transduction and has 
a vital role in cellular homeostasis. Any defect in its turnover may cause blockage of 
proliferation and initiation of apoptosis since calcium metabolism is important for the cell 
cycle regulation (Humeau et al., 2018). Excess calcium in the cell is stored in ER and its 
intracellular signaling initiates from ER to other cellular compartments. Therefore, any 
fault in intracellular Ca+2 balance results in ER stress (Krebs, Agellon, & Michalak, 
2015). Recent studies showed that upregulation of TRPV6 protein results in the increase 
of Ca+2 level and causes ER stress mediated apoptosis (J. K. Lau et al., 2014). In contrast, 
TRPV6 knockdown led to initiation of apoptosis since TRPV6 promotes cell survival by 
providing apoptosis resistance in cancer (Raphaël et al., 2014). It was reported that ER 
stress caused by elevated Ca+2 level is closely associated with autophagy regulation apart 
from apoptosis (X. Chen, Li, & Zhao, 2018; Høyer-Hansen & Jäättelä, 2007).  
Since the expression of TRPV6 and PKCδ were reported in different type of cancer cells, 
we decided to perform further experiments in HeLa cell line. In order to apply gene 
transfer in HeLa cells stably expressing GFP-LC3, we carried out different transfection 
methods. While, Amaxa transfection demonstrated the highest efficiency, CaPO4 
transfection gave the lowest efficiency (Figure 5.11-12). However, the transfection 
efficiency was proportional to cell death. Therefore, we preferred to use Lipofectamine 
2000 which has second efficient transfection results in order to avoid excessive cell death 
during transfection process. At first, TRPV6 expression and the effect of PMA on 
autophagy regulation were confirmed in HeLa GFP-LC3 stable cells under basal 
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condition.  In MEF GFP-LC3 transgenic cells, PMA treatment caused an increase in 
PKCδ protein expression while autophagy was attenuated under this condition. 
Surprisingly, PMA increased both PKCδ and TRPV6 protein expression compared to 
both vehicle control and starvation induced condition in HeLa cells (Figure 5.13). It was 
reported that the change in Ca+2 level due to ER stimulation caused autophagy activation 
however there is not any data regarding to TRPV6 dependent autophagy regulation. Thus, 
it was important to check the interaction of TRPV6 and PKCδ by establishing 
overexpression and knockdown experiments.  
Our findings demonstrated that upon PMA exposure, autophagy was inhibited due to 
PKCδ activation. However, PKCδ overexpression caused an increase in the autophagy 
mechanism upon PMA treatment. This increase might be due to the contrary effect of 
cellular mechanisms in order to keep cellular homeostasis under excessive amount of 
PKCδ protein. Meanwhile, in these cells, PMA treatment caused the increase in TRPV6 
protein expression in both basal and starvation-induced condition (Figure 5.14). One 
possibility is that upregulation of PKCδ caused the change in TRPV6 activity and led to 
Ca+2 dependent ER stress and eventually contributed the increase in autophagy under 
PMA treatment. The another one is that other PKC isozymes activated by PMA may take 
place in the signaling mechanism and caused the increase in ER stress independent 
autophagy regardless of TRPV6 activation.   
The next step was confirmation of autophagy activity and TRPV6 expression under PKCδ 
silenced conditions. We expected that under the suppression of PKCδ, TRPV6 protein 
level could be decreased because both PMA treatment and PKCδ overexpression caused 
increase in the TRPV6 protein expression. However, it was observed that the expression 
level of TRPV6 was higher in PKCδ silenced cells under both PMA and starvation 
induced condition (Figure 5.15). PKCδ downregulation affected TRPV6 expression 
significantly because TRPV6 could interact with other PKC isozymes in order to stabilize 
channel activity and to normalize intracellular Ca+2 concentration in the absence of 
enough PKCδ activity. In the literature PKCα dependent phosphorylation of TRPV6 
resulted in the change of channel function (Niemeyer, Bergs, Wissenbach, Flockerzi, & 
Trost, 2001). However, PKCα activation depends on Ca+2 so other signaling pathways 
may ensue to regulate TRPV6 stimulation under PKCδ silenced condition.  
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These results showed that there is a momentous interaction between PKCδ and TRPV6. 
The regulation of TRPV6 depends on PKCδ however we wonder whether PKCδ 
expression relates to the change in TRPV6 expression. In order to examine this 
hypothesis, we downregulated TRPV6 expression by siRNA silencing to determine both 
autophagic activity and PKCδ expression. Consistent with MC3 cells, suppression of 
TRPV6 increased the autophagy upon PMA treatment compared to control in HeLa cells. 
However, TRPV6 downregulation did not change the PKCδ expression (Figure 5.17). 
Therefore, the relation between PKCδ and TRPV6 is not mutual. In the literature, TRPV6 
works both alone or dual with TRPV5 and they have a similar role in Ca+2 regulation. 
Thus, TRPV5 can substitute TRPV6 role in Ca+2 metabolism under the absence of 
TRPV6.  
The change in TRPV6 expression could not cause differences in PKCδ level so we 
hypothesized that the phosphorylation of TRPV6 by PKCδ may happen. Before 
experimental process, we aimed to determine possible phosphorylation sites on TRPV6 
by PKCδ by using different bioinformatics tools. Interestingly, there were several 
phosphorylation sites detected and the most common sites located on the N terminus of 
TRPV6 which is crucial for function of channel activity (Table 5.1, Figure 6.1). 
Obviously to be determine which sites is important for PKCδ interaction during 
autophagy regulation, in-depth search should be applied. Our preliminary findings are 
important because of introducing novel signaling pathway of PKC on autophagy 
mechanism. Investigation of this pathway will contribute the understanding of PKCδ 
dependent autophagy activation associated with calcium metabolism clearly.  
 
Figure 6.1. Possible phosphorylation sites on TRPV6 targeted by PKCδ were shown in 
yellow. 
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7. FUTURE PERSPECTIVE 
 
In this M.Sc. thesis, it was described that PKCδ isozyme interacts with TRPV6, which 
could have a significant impact on autophagy regulation. The exact mechanism of this 
interaction could not be identified so far. Our study might be critical, because we 
investigated possible linker signaling member, TRPV6, to clarify PKCδ mediated 
autophagy regulation. There are several phosphorylation sites on TRPV6 targeted by 
PKCδ and point mutations on these sites will lighten the site-specific interaction between 
TRPV6 and PKCδ. In addition to phosphorylation, the interactions between TRPV6 and 
PKCδ should be shown by co-immunoprecipitation assays to understand the relation 
between PKCδ and TRPV6 in terms of binding.  
Also, intracellular Ca+2 levels should be determined under each treatment condition in 
order to predict whether these data are related to ER stress-mediated autophagy. 
Depending on the Ca+2 level analysis, Ca+2 induced PKCα activation may be checked 
under both PMA and ionomycin treatment. It is already shown that PKCα can 
phosphorylate TRPV6. It will clarify whether the change in TRPV6 is depending on PMA 
or Ca+2 concentration. Flow cytometry analysis after FURA-2AM exposure may give idea 
about cytoplasmic Ca+2 concentration related with TRPV6 activity. Also, ER stress 
inducers such as tunicamycin or thapsigargin may be used as positive control of ER stress 
during analysis of Ca+2 level in cells after PMA and starvation treatments. Also, Ca+2 
concentration in ER maybe visualized under fluorescence microscopy after FURA 2AM 
staining and this will contribute the comparison of TRPV6 role in Ca+2 concentration both 
in ER and cytoplasm. 
PKC isozymes may have contrary effects on autophagy depending on the cell types. In 
order to show PKCδ and TRPV6 relation, different cancer cell lines might be used to 
confirm this interaction on autophagy mechanism.  
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